-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pollinex Quattro Tree in Pollen Allergy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Pollinex Quattro Tree in Pollen AllergyDrug Details:TreeMATA MPL is under development for the treatment of pollen...
-
Thematic Analysis
New![]()
Media Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q3 2023 in the Media Sector
-
Sector Analysis
New![]()
Luxury Hotels Market Size and Forecast, Key Trends, Company Profiles, 2023 Update
GlobalData’s Luxury Hotels Market report provides in-depth analysis of the key market trends that are shaping the future of this segment and an analysis of the luxury accommodation market globally. Detailed market insight is provided on the Americas, Asia-Pacific, Middle East & Africa, and Europe. It also features profiles of some of the market’s leading players and looks at how companies can better meet their customers' needs.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Gallbladder Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Gallbladder Cancer Drug Details: GEN-001 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Extrahepatic Bile Duct Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Extrahepatic Bile Duct Cancer Drug Details: GEN-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Adenocarcinoma Of The Gastroesophageal Junction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details: GEN-001 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Gastric Cancer Drug Details: GEN-001 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GEN-001 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GEN-001 in Solid Tumor Drug Details: GEN-001 is under development for the treatment of solid...
-
Sector Analysis
New![]()
China Destination Tourism Trends Insight by Type, Source Markets, Foreign Direct Investment and Future Opportunities, 2023 Update
China Destination Tourism Insight Report Overview The total number of international arrivals in China amounted to 3.7 million in 2022. Domestic travel dominates China's tourist income. Furthermore, the tremendous economic expansion over the last 40 years has encouraged the development of inbound tourism through quick and much-needed improvements in infrastructure. Tourism has undeniably emerged as a pivotal contributor to the Chinese economy, assuming a position as the nation's foremost service export. Infrastructure has played a very important role in tourism...
-
Product Insights
![]()
Banyan Tree Hotels – Banyan Tree Veya Bacalar Resort Development – Yucatan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Banyan Tree Hotels - Banyan Tree Veya Bacalar Resort Development - Yucatan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Vaccine For Grass Pollen Allergy And House Dust Mite Allergy in House Dust Mite Allergy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Vaccine For Grass Pollen Allergy And House Dust Mite Allergy in House Dust Mite AllergyDrug Details:Vaccine...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Paclitaxel Albumin Bound in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel Albumin Bound in Triple-Negative Breast Cancer (TNBC) Drug Details: Paclitaxel albumin bound (Paclitaxel) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Paclitaxel Albumin Bound in Metastatic Biliary Tract Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Paclitaxel Albumin Bound in Metastatic Biliary Tract Cancer Drug Details:Paclitaxel albumin bound (Paclitaxel) is a cyclodecane...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Paclitaxel Albumin Bound in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel Albumin Bound in Gastric Cancer Drug Details: Paclitaxel albumin bound (Paclitaxel) is a cyclodecane...
-
Product Insights
![]()
Trees for Life – Dundreggan Visitor Centre – Highland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Trees for Life - Dundreggan Visitor Centre - Highland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
![]()
A1 Dev – Hickory Tree Tower – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our A1 Dev - Hickory Tree Tower - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Irinotecan Hydrochloride in Gallbladder Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Irinotecan Hydrochloride in Gallbladder Cancer Drug Details: Irinotecan Hydrochloride (Onivyde) is a semisynthetic derivative of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Irinotecan Hydrochloride in Osteosarcoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Irinotecan Hydrochloride in Osteosarcoma Drug Details: Irinotecan Hydrochloride (Onivyde) is a semisynthetic derivative of camptothecin,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Irinotecan Hydrochloride in Fallopian Tube Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Irinotecan Hydrochloride in Fallopian Tube Cancer Drug Details: Irinotecan Hydrochloride (Onivyde) is a semisynthetic derivative...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Irinotecan Hydrochloride in Pancreatic Ductal Adenocarcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Irinotecan Hydrochloride in Pancreatic Ductal Adenocarcinoma Drug Details: Irinotecan Hydrochloride (Onivyde) is a semisynthetic derivative...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.